Benefiting from Bristol Myers’ input, ConcertAI rolls out digital trial solution

By Nick Taylor

- Last updated on GMT

© metamorworks / Getty Images
© metamorworks / Getty Images

Related tags: Bristol Myers Squibb, Patient centricity, Clinical trials

ConcertAI has introduced a digital trial solution informed by its collaboration with Bristol Myers Squibb to simplify patient identification, consent, IRB approval, and contract negotiations.

Bristol Myers teamed up with ConcertAI, a developer of real-world evidence (RWE) solutions, early in 2019 to use its partner’s data and technologies in parts of its research enterprise. The collaboration led to Bristol Myers helping to shape ConcertAI’s digital trial solution, as Jeff Elton, CEO of the RWE startup, explained.

With that foundation of working together on an array of new innovations, we were able to set demanding standards for what digital trial solutions would provide, bring years of experience to bear, access narrow expertise rapidly, and predictably move the solution into use​,” said Elton.

In discussing how Bristol Myers helped to shape the clinical trial offering, Elton explained that building novel solutions in a regulated industry “requires enormous domain and technical expertise​” and “a lot of integration across multiple functions and groups within the company​.”

The result is a solution designed to ultimately reduce or eliminate duplicative data entry and constant data monitoring, thereby freeing clinical research staff to focus their time on patient care. ConcertAI has set up the solution to integrate directly into practices' clinical workflows, including electronic medical records, imaging and lab systems, to improve the identification of potential research participants.

Bristol Myers has now enrolled its first participant through the Digitally Accelerated Clinical Trial model, a milestone that its vice president, R&D business insights and analytics, said demonstrates the company’s “commitment to use data and technology to simplify and accelerate the clinical research process​.”

ConcertAI's first deployments are underway and it has a schedule of network expansions planned for the coming months as it works to create “the largest digitally enabled oncology, hematology and urology research capacity in the industry​.” Elton outlined how the solution reflects the needs of sites.

Each site has a set of technical solutions integrated into its clinical workflows and supporting the research team​,” the CEO said. ​“While the tools and solutions are standard, healthcare clinical and research administrative systems vary tremendously, so there can be a modest to a heavy lift to put these into place​.”

Related news

Related products

show more

Using SDTM, ADaM, and SEND

Using SDTM, ADaM, and SEND

Formedix | 09-Nov-2022 | Technical / White Paper

This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...

How to design an effective CRF

How to design an effective CRF

Formedix | 10-Oct-2022 | Technical / White Paper

CRFs and eCRFs are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical...

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Because When It's On the Line... Capability Matters.

Because When It's On the Line... Capability Matters.

Baxter BioPharma Solutions | 01-Oct-2022 | Product Brochure

Baxter’s BioPharma Solutions business supports leading pharmaceutical companies in meeting their commercialization objectives by providing scientific expertise,...

Related suppliers

Follow us

Products

View more

Webinars